NewsRoom Articles - Page 188 of 596

ThursdayApr 07, 2022 4:20 am

420 with CNW — Increasing Fuel Prices Are Pushing Marijuana Delivery Companies to Go Electric

The price of gasoline is increasing rapidly in various parts of North America, including in Canada and the United States. Figures from the American Automobile Association show that as of last week, the average price of gasoline has jumped to $4.25 per gallon, which is quite an increase when compared to its $2.87 per gallon price for last year. The Canadian Automobile Association has also observed the same upward trend, with the average national price of gasoline increasing to CA$ 1.72 per liter from its cost last year of CA$ 1.22 per liter. This increase has put pressure on marijuana…

WednesdayApr 06, 2022 4:20 pm

420 with CNW — Pastor Promotes the Spiritual Aspects of Cannabis Use

The last person you would expect to use cannabis would be a “person of the cloth.” However, Craig Gross isn’t a conventional Christian. Like many people who grew up during the prohibition era, he’s heard plenty of stories regarding the evils of cannabis. And in Gross’ case, he may have been taught to avoid drugs such as cannabis. Despite that, Gross, now a Christian evangelist and entrepreneur, uses cannabis to alleviate a physical condition. Actually using marijuana after years and years of negative messaging required plenty of mental fortitude. Once Gross made the leap, the controversial plant provided effects he…

WednesdayApr 06, 2022 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potential InMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to the health and wellness market in the coming months, following on the heels of its CBC and CBT products The company recently reported its first revenues from CBC sales in the wake of its acquisition of rare cannabinoids manufacturer BayMedica late last year The company is also working to develop synthetic CBN cannabinoids as potential medical treatments for select conditions,…

WednesdayApr 06, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Lexaria is a global innovator that has developed the patented DehydraTECH(TM) technology that improves bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“APIs”) The company strategically partners with third-party organizations seeking to explore formulation opportunities with their specific APIs Lexaria is evaluating the effectiveness of various DehydraTECH-processed APIs, including CBD, nicotine, sildenafil, and more According to company CEO Chris Bunka, the management team is positioning the company to ensure that it has multiple paths to success In pursuit of multiple paths to success, Lexaria Bioscience (NASDAQ: LEXX), developer of the patented DehydraTECH(TM) drug delivery platform, strategically partners…

WednesdayApr 06, 2022 4:20 am

420 with CNW — Genetic Testing and CBD Offers Hope to Children with Intractable Epilepsy

Epilepsy is a neurological condition that causes an individual to have recurrent and unprovoked seizures. Estimates show that roughly 470,000 children in the United States are living with epilepsy. The condition is usually diagnosed when an individual suffers from at least two seizures 24 hours apart. Epilepsy can be genetic, with research discovering more than 500 genes that may be linked to the disorder. It can also be brought about by fevers, infection, traumatic brain injuries and autoimmune diseases, which is referred to as acquired epilepsy. Despite the presence of a number of anti-seizure medications that can be prescribed to…

TuesdayApr 05, 2022 4:20 pm

420 with CNW — Firm Selected by DEA to Cultivate Research-Grade Marijuana Seeks NASDAQ Listing

A Fort Lauderdale, Florida-based company that has been tapped by the U.S. Drug Enforcement Administration (DEA) to cultivate cannabis for scientific research could soon make history by becoming the first American cannabis company to trade its shares on Nasdaq. Bright Green Corp. recently filed paperwork with the U.S. Securities and Exchange Commission to trade its shares under the moniker BGXX on the Nasdaq market. The Florida company noted in its SEC filing that the DEA had granted it “conditional approval” to produce cannabis for research purposes. Once the cannabis company receives regulatory approval, investment advisor EF Hutton will calculate its…

TuesdayApr 05, 2022 4:20 am

420 with CNW — Gamers Could See Cognitive Performance Boost from CBD

Competitive gamers usually undergo random drug screening for performance-enhancing drugs in various leagues, including the Electronic Sports League. CBD and THC are both compounds found in cannabis. While both compounds possess a number of beneficial properties, THC induces a high when consumed. THC (tetrahydrocannabinol) is one of the compounds that the league screens for. This compound may worsen mechanics that are necessary for gaming, including basic motor coordination for tasks such as organizing, making decisions and solving problems. Many believe that it is CBD (cannabidiol), instead, which should be screened for given the compound’s potential to enhance cognitive performance. Preliminary…

MondayApr 04, 2022 4:20 pm

420 with CNW — Biotech Firm Identifies Possible Pathways Explaining How Cannabis Could Help Kids With Autism

Decades after the United States outlawed cannabis and carried out a drug war that had devastating effects on Black and Brown communities, the controversial plant is gaining popularity as an alternative medicine. Although prohibition has significantly hindered cannabis research, studies show that cannabis can be effective against some medical conditions including chronic pain and post-traumatic stress disorder (PTSD). An early-stage biotech startup called Cannaformatics has recently published research in the “Cannabis and Cannabinoid Research” journal, showing how cannabis can interact with pathways in the brain to reduce autism in kids. Titled “The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate…

MondayApr 04, 2022 9:30 am

American Cannabis Partners Helps Michigan Achieve Record Cannabis Sales

Michigan continues to break sales records in the cannabis sector ACP currently operates in Michigan and California and is exploring strategies for expanding operations to two more states The company is focused on three business segments: real estate, acquisition and development of proprietary assets, and ongoing cultivation operations Cannabis sales numbers for December 2021 are in, and Michigan has broken another record (https://cnw.fm/rKoPX). This is the kind of news that cannabis operators in the state, including American Cannabis Partners (“ACP”), love to hear. “Michigan closed out 2021 with another record-breaking month of adult-use marijuana sales in December, state officials say,”…

MondayApr 04, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), Building a House of Brands, Is Creating World-Class Standards for Environmental Impact, Social Justice, and Corporate Governance, to Navigate Increasing Commoditization in its Market Segment

Red White & Bloom, a multi-state operator in cannabis and hemp-derived product lines, has built a platform to strengthen its brands, enabling it to wade through the difficulties of increasing product commoditization The company expects to showcase the results of the buildout process in the coming months RWB is also committed to fostering public and local input, equitable leadership opportunities, and removing systemic structures that marginalize segments of society A Boston Consulting Group (“BCG”) article entitled “Escaping the Doghouse: Winning in Commoditized Markets” notes that a company needs a clear roadmap that shows how it can reorganize itself for the…